T1	Participants 274 291	patients with CFS
T2	Participants 759 788	patient with symptoms of CFS.
T3	Participants 813 966	patient had either "chronic fatigue syndrome," "chronic neuroendocrineimmune dysfunction syndrome," or "chronic neuroendocrineimmune dysfunction syndrome
